Anavex Life Sciences Corp (AVXL)

[OFP]

If the drug can maintain or restore the degraded myelin of nerves with multiple sclerosis, good chance, at least to some degree, it could do that for individuals with Charcot–Marie–Tooth disease.

A demyelinating vs. a primarily dysmyelinated disease. One might expect better prospect in a demyelinating disease though results to date are underwhelming to say the least.